Non-invasive prostate cancer test boosts early treatment
Non-invasive prostate cancer test boosts early treatment"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Along with ExoDX, such newer tests include: SELECTMDX. This urine test assesses a man's risk for aggressive prostate cancer to help identify which patients may truly benefit from a
biopsy. A 2019 study published in the _Journal of Clinical Oncology_ found that it was more useful than the Prostate Health Index in picking up aggressive cancers that required biopsy.
ISOPSA. This blood test, invented by the Cleveland Clinic and FDA approved in late 2019, identifies molecular changes in PSA that can indicate cancer, says Eric Klein, M.D., chair of
Cleveland Clinic's Glickman Urological & Kidney Institute. It's been shown to reduce unnecessary prostate biopsies by about 45 percent. MIR SCIENTIFIC'S SENTINEL TEST.
This urine-based test, which became available this year, can categorize patients into one of four groups: no cancer, low-risk cancer, intermediate-risk cancer or high-risk cancer. If you
have an elevated PSA, Klein recommends following up with any of the above tests, including one of the older ones. (It may boil down to which tests are available at your medical center, and
what's covered by your insurance.) If you have a test done and it's negative, you can just be followed closely with annual PSA screening. If it's positive, the next step
should be a prostate MRI as well as a biopsy. An MRI is important, Klein explains, because it can show if the cancer has spread “right outside the prostate into, say, the seminal vessels.”
Ripken, for one, credits the ExoDx prostate test with convincing him to go ahead and have the biopsy. “With the uncertainty of what a PSA result means, it's easy to just dismiss it and
say you'll come back in six months or a year and look at it again,” he explains. But once he got his results back, “it really gave me a different perspective. It gave me confidence that
a biopsy was the right course of action.” Today, Ripken is back to doing all his regular activities, including biking, with no side effects. “My story had a happy ending: We caught it
early, and my life went back to how it was before,” he says. “All men should be able to have that."
Trending News
Revaluating the relationship between keratoplasty and intraocular lensesWe read the article published this month with interest and raising awareness of this concern should be relevant to all s...
Javascript support required...
Bet proteolysis targeted chimera-based therapy of novel models of richter transformation-diffuse large b-cell lymphomaABSTRACT Richter Transformation (RT) develops in CLL as an aggressive, therapy-resistant, diffuse large B cell lymphoma ...
Excitatory action of hypothalamic substance p on spinal motoneurones of newborn ratsABSTRACT IT is generally believed that the primary afferent fibres constituting the spinal dorsal roots, form excitatory...
Knowing when to stop | Nature AstronomyWhen do we stop an ongoing science project to make room for something new? Decision-making is a complex process, ranging...
Latests News
Non-invasive prostate cancer test boosts early treatmentAlong with ExoDX, such newer tests include: SELECTMDX. This urine test assesses a man's risk for aggressive prostat...
Page Not Found很抱歉,你所访问的页面已不存在了。 如有疑问,请电邮[email protected] 你仍然可选择浏览首页或以下栏目内容 : 新闻 生活 娱乐 财经 体育 视频 播客 新报业媒体有限公司版权所有(公司登记号:202120748H)...
The aarp minute: february 5, 2020Memorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...
Page Not Found很抱歉,你所访问的页面已不存在了。 如有疑问,请电邮[email protected] 你仍然可选择浏览首页或以下栏目内容 : 新闻 生活 娱乐 财经 体育 视频 播客 新报业媒体有限公司版权所有(公司登记号:202120748H)...
Brum ‘so much bigger than city council’ - departing lord mayorBIRMINGHAM'S LORD MAYOR KEN WOOD ACKNOWLEDGED THE TURMOIL THAT MANY BRUMMIES HAVE FACED IN RECENT TIMES 13:29, 20 M...